Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000674478 | SCV000799821 | likely pathogenic | Xeroderma pigmentosum, group C | 2018-05-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001381047 | SCV001579299 | pathogenic | not provided | 2021-08-24 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Tyr430*) in the XPC gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in XPC are known to be pathogenic (PMID: 23173980, 25256075). This variant is not present in population databases (ExAC no frequency). A different variant (c.1290_1295delTAAAGA) giving rise to the same protein effect has been determined to be pathogenic (PMID: 16081512). This suggests that this variant is also likely to be causative of disease. ClinVar contains an entry for this variant (Variation ID: 558241). For these reasons, this variant has been classified as Pathogenic. |